Silo Pharma Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Silo Pharma Inc's ROI in the second quarter of 2026?
Silo Pharma Inc recorded a cumulative net loss of $-4 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -74.39%.

Within the Healthcare sector 539 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3349 to 3890.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	7.94 %	10.08 %	-2.54 %	-17.85 %	-18.65 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	5	6	7	6	6
Return On Investment (TTM)	-74.39 %	-78.01 %	-72.78 %	-95.59 %	-87.89 %
SILO's Overall Ranking	# 3890	# 3349	# 3442	# 3183	#
Seq. Investment Change TTM	-3.17 %	6.88 %	9.38 %	-4.64 %	-1.25 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-4	-5	-4	-5	-5

SILO Company Profile >> Back to SILO Roi Comparisons >> See Annual SILO Return On Investment

Return On Investment SILO's Ranking
Within:	No.
Industry	# 238
Sector	# 540
Overall	# 3890

Return On Investment Statistics
High	Average	Low
101.78 %	-208.11 %	-4480 %
(Sep 30 2021)		(Sep 30 2012)

News about Silo Pharma Inc Return on Investment ROI

Silo Pharma and Sever Pharma Usher in a New Era of Pain Management with Innovative Ketamine Implant Therapy

August 14, 2024

In recent developments within the realm of chronic pain management, Silo Pharma, a biopharmaceutical company dedicated to the development of innovative therapeutic solutions, has announced an expansion of its development agreement with Sever Pharma. This collaboration aims to enhance the research and development of SP-26, a groundbreaking dissolvable ketamine-based injectable implant designed specifically to target chronic pain and fibromyalgia.Chronic pain syndromes, including fibromyalgia, have long posed significant challenges for healthcare providers and patients alike, often resulting in debilitating physical and emotional consequences. Current treatment modalities range from traditional pharmacological approaches to alternative therapies; however, many of these options fall short in efficacy or come with a host of undesirable side effects. As medical research increasingly pursues novel approaches to pain management, the focus is shifting toward innovative therapies with potentially transformative effects.

Financial Statements
Silo Pharma Inc's II. Quarter Investments	$ 5 Millions	SILO's Balance sheet
Silo Pharma Inc's II. Quarter Income	$ -1 Millions	Quarterly SILO's Income Statement
SILO's Income by Division		See SILO's Income by Division

SILO Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	6	5	7	11	10
Y / Y Investment Growth	25.25 %	-28.61 %	-37.07 %	12.06 %	678.26 %
Net Income in Millions	-4	-4	-4	-4	4
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-67.05 %	-87.26 %	-52.48 %	-34.88 %	39.04 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SILO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SILO's Competitors
Subscribers only: Roi for Silo Pharma Inc's Suppliers
Subscribers only: Return On Investment for SILO's Customers

Other Ratios
SILO's Roa	SILO's Inventory Turnover Ratio	SILO's Growth Rates	SILO's Dividend Statistics
	SILO's Profitability Ratios	SILO's Asset Turnover Ratio	SILO's Dividend Growth
SILO's Roe	SILO's Valuation Ratios	SILO's Financial Strength Ratios	SILO's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:36:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.